Nicholas Jarjour to Join Versiti Blood Research Institute!
Versiti Blood Research Institute shared on LinkedIn:
”Please join us in welcoming Nicholas Jarjour, PhD to Versiti Blood Research Institute!
He is joining VBRI as an associate investigator in Hematopoiesis and Immunology.
Dr. Jarjour earned his PhD at Washington University in St. Louis and completed postdoctoral training at the University of Minnesota.
His research explores the evolution of tissue-resident immunity: how immune cells living within organs support health, respond to disease, and adapt over time.
When asked what his Versiti spark is, Dr. Jarjour said, “It’s the opportunity to discover what we’ve never known before and try to use that to improve human health.
It’s an incredible privilege. Not a lot of people get to do that.”
Read more about Dr. Jarjour and the other new associate investigator joining Versiti.”
Stay updated with Hemostasis Today.
-
Oct 9, 2025, 06:44Gretchen Simmons: Anyone Can Have a Blood Clot - No One Knows This Better Than Carol West
-
Oct 8, 2025, 03:07Stroke Education By Rodrigo Guerrero - On Unilateral, Nonprogressive Stenosis
-
Oct 7, 2025, 15:015 Simple Exercises By Christina P. That Support Health in Antiphospholipid Syndrome
-
Oct 7, 2025, 14:39Dr Amid Karad: Help Raise Awareness on Evidence-Based INR Management for Diverse Indications
-
Oct 7, 2025, 14:27NBCA Insights with Erin VanDyke: Revealing Gaps in Blood Clot Diagnosis and Support
-
Oct 10, 2025, 03:09Giuseppe Lippi: We Show Here That Red Light Therapy Offers Promise in High-Risk Patients
-
Oct 10, 2025, 01:58Emilya Huseynova: Excited to Share That My Work On Blood Safety Monitoring Has Just Been Published by Transfusion
-
Oct 9, 2025, 07:14Ami Bhatt: The link Between Inflammation and Atherosclerotic Cardiovascular Disease Is No Longer Theoretical
-
Oct 9, 2025, 06:59Courtney Lawrence: It's Critical That as Blood Donor Eligibility Criteria Evolves, We Ensure the U.S. Blood Supply for Patients Remains Safe!
-
Oct 9, 2025, 06:55All You Need to Know About Generative AI in Medicine from Daniel Ting and Colleagues
-
Oct 7, 2025, 13:06Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 3, 2025, 15:07Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
-
Oct 2, 2025, 04:59Caterina Casari - Prizes for Innovators 2025 Winner!
-
Oct 10, 2025, 03:10Marilena Vrana: Plasma-Derived Medicines Are a Clear Example of Why A One-Size-Fits-All Approach Won’t Work
-
Oct 10, 2025, 03:07Nancy Di Salvo: It's IPAW 2025, How Could I Not Take a Moment to Thank Every Single Plasma Donor Out There?
-
Oct 10, 2025, 03:06Anita Brikman: Increasing Awareness of The Ongoing Need for Plasma Donors Is Vital to Ensuring Patient Access and Continuity of Care
-
Oct 10, 2025, 03:04Stephen Cornelissen: A New Plasma Drop Has Been Added to Lifeblood’s Blood Supply Tracker
-
Oct 10, 2025, 02:12Bethany Samuelson Bannow Welcomed to Department of Hematology and Medical Oncology at the Cancer Institute Cleveland Clinic